Acquired hemophilia A (AHA) due to anti‐SARS‐CoV‐2 vaccination: A systematic review
Acquired hemophilia A (AHA) due to anti‐SARS‐CoV‐2 vaccination: A systematic review
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Vaccination against SARS‐CoV2 has been the largest vaccination campaign over the past two decades. The aim of this study is to qualitatively assess the reported cases of acquired hemophilia A (AHA) that developed after COVID‐19 vaccination to further elaborate on incidence, presentation, treatment, and outcomes.We queried Medline (PubMed), Google S...
Alternative Titles
Full title
Acquired hemophilia A (AHA) due to anti‐SARS‐CoV‐2 vaccination: A systematic review
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_22df74f90cd240b1a8d1dd6c210daad9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_22df74f90cd240b1a8d1dd6c210daad9
Other Identifiers
ISSN
2688-6146
E-ISSN
2688-6146
DOI
10.1002/jha2.604
